Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

NIH to fund UCLA alcoholism study of MediciNova's MN-166

Aug. 26, 2013

Lightlake Therapeutics and NIH partner to develop intranasal naloxone for opioid overdose

Aug. 22, 2013

Atlantic Pharmaceuticals completes pre-IND meeting with FDA for abuse-deterrent hydrocodone

Aug. 16, 2013

Orexo begins dosing in two trials evaluating early and long-term treatment with Zubsolv

Aug. 8, 2013

BioDelivery Sciences submits NDA to FDA for Bunavail

Aug. 2, 2013

Signature Therapeutics receives award to advance abuse-deterrent oxycodone

Aug. 2, 2013

Invion begins phase II INV-102 trial

July 26, 2013

Novel drug and drug target for the treatment of addictive disorders characterized

July 24, 2013

Pluristem's PLX cells tested for treatment of radiation poisoning

July 17, 2013

Novel kappa receptor antagonists disclosed by Research Triangle Institute

July 1, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...